$12.3B
$5.65 Million
0.0% of portfolio
78,214
Q3 2024
Reduced 48.92%
$319M
$406,000
0.0% of portfolio
38,776
Q3 2024
Reduced 59.17%
$342M
$205,000
0.0% of portfolio
6,286
Q3 2024
Reduced 14.71%
$23B
$1.85 Million
0.0% of portfolio
79,283
Q3 2024
Reduced 91.39%
$18.1M
$46,000
0.0% of portfolio
29,580
Q3 2024
New
$15B
$4.76 Million
0.0% of portfolio
21,857
Q3 2024
Reduced 63.2%
$85.2M
$12,000
0.0% of portfolio
10,818
Q3 2024
Reduced 58.43%
$560M
$1.31 Million
0.0% of portfolio
185,329
Q3 2024
Reduced 6.59%
$17.1B
$19.6 Million
0.0% of portfolio
67,886
Q3 2024
Reduced 62.05%
$95B
$224,000
0.0% of portfolio
4,728
Q3 2024
Reduced 89.69%
$3.91B
$2.09 Million
0.0% of portfolio
156,236
Q3 2024
Reduced 45.52%
$0
$1.73 Million
0.0% of portfolio
40,280
Q3 2024
Added 44.77%
Renaissance Cap Greenwich Fd
-
$0
0.0% of portfolio
-
Q3 2024
New
$11.2B
$7.49 Million
0.0% of portfolio
27,523
Q3 2024
Reduced 19.67%
$2.03B
$910,000
0.0% of portfolio
28,019
Q3 2024
Reduced 42.69%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 6.83%
$244M
$95,000
0.0% of portfolio
20,862
Q3 2024
Reduced 41.76%
$673M
$409,000
0.0% of portfolio
50,166
Q3 2024
Reduced 40.02%
$9.32B
$11 Million
0.0% of portfolio
74,213
Q3 2024
Reduced 41.66%
$500M
$2.87 Million
0.0% of portfolio
262,248
Q3 2024
Reduced 51.1%
$1.2B
$298,000
0.0% of portfolio
4,570
Q3 2024
Reduced 30.4%
$509M
$425,000
0.0% of portfolio
53,018
Q3 2024
Added 22.51%
$3.34B
$3.31 Million
0.0% of portfolio
164,229
Q3 2024
Reduced 27.27%
$36.3B
$15.3 Million
0.0% of portfolio
62,537
Q3 2024
Reduced 74.59%
$287M
$1.56 Million
0.0% of portfolio
160,575
Q3 2024
Reduced 48.89%
$18.6B
$5.14 Million
0.0% of portfolio
71,269
Q3 2024
Reduced 93.03%
$2.17B
$1.89 Million
0.0% of portfolio
120,250
Q3 2024
Reduced 13.48%
$26M
$9,000
0.0% of portfolio
12,689
Q3 2024
New
$2.04B
$988,000
0.0% of portfolio
35,243
Q3 2024
Reduced 28.16%
$212M
$1.46 Million
0.0% of portfolio
568,654
Q3 2024
Added 246.92%
$0
$1,000
0.0% of portfolio
50,000
Q2 2023
Reduced 38.08%
$3.53B
$8.2 Million
0.0% of portfolio
180,897
Q3 2024
Reduced 52.47%
$1.22B
$3.36 Million
0.0% of portfolio
135,439
Q3 2024
Reduced 33.16%
$15.3B
$4.92 Million
0.0% of portfolio
40,629
Q3 2024
Reduced 80.16%
$7.45B
$4.29 Million
0.0% of portfolio
85,273
Q3 2024
Reduced 11.5%
$5.75B
$5.21 Million
0.0% of portfolio
167,722
Q3 2024
Added 758.88%
$10.8B
$13.4 Million
0.0% of portfolio
39,964
Q3 2024
Reduced 61.9%
$3.21B
$5.72 Million
0.0% of portfolio
109,186
Q3 2024
Reduced 25.47%
$675M
$244,000
0.0% of portfolio
75,290
Q3 2024
Reduced 20.65%
$159M
$191,000
0.0% of portfolio
15,545
Q3 2024
Added 8.23%
-
$0
0.0% of portfolio
-
Q3 2024
New
Rigel Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 75.83%
$1.7B
$190,000
0.0% of portfolio
244,496
Q3 2024
Added 23.81%
$0
$4,000
0.0% of portfolio
51,070
Q1 2024
Reduced 0.01%
$247M
$90,000
0.0% of portfolio
48,680
Q3 2024
Reduced 49.51%
$195M
$121,000
0.0% of portfolio
75,833
Q3 2024
Reduced 42.22%
$2.93B
$9.61 Million
0.0% of portfolio
303,757
Q3 2024
Reduced 19.26%
$100B
$11.2 Million
0.0% of portfolio
157,594
Q3 2024
Added 57.93%
$2.24B
$7.31 Million
0.0% of portfolio
985,728
Q3 2024
Reduced 68.32%
$467M
$58,000
0.0% of portfolio
12,375
Q3 2024
Reduced 73.66%